The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 10,380 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 7,000 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
| ALLAKOS INC | COM | 01671P100 | 3,374 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 15,316 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 5,250 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| ANAPTYSBIO INC | COM | 032724106 | 5,986 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 3,289 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
| AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 1,465 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| ARGENX SE | SPONSORED ADR | 04016X101 | 9,480 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 2,952 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 12,071 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 15,944 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 1,976 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 3,815 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL IN | COM | 09060J106 | 4,200 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 7,510 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 10,950 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 2,156 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 16,786 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
| ENDOCYTE INC | COM | 29269A102 | 19,536 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
| EDGE THERAPEUTICS INC | COM | 279870109 | 820 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 1,222 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| INVESCO CURNCYSHS SWISS FRAN | SWISS FRANC | 46138R108 | 12,266 | 128,700 | SH | SOLE | 128,700 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 456 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 4,500 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 2,250 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| GLYCOMIMETICS INC | COM | 38000Q102 | 5,760 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| GENOCEA BIOSCIENCES INC | COM | 372427104 | 2,748 | 3,525,000 | SH | SOLE | 3,525,000 | 0 | 0 | ||
| GRITSTONE ONCOLOGY INC | COM | 39868T105 | 1,068 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 18,410 | 883,823 | SH | SOLE | 883,823 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 526 | 26,000 | SH | SOLE | 26,000 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 4,975 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| KADMON HLDGS INC | COM | 48283N106 | 6,680 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 4,025 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 3,041 | 14,200 | SH | SOLE | 14,200 | 0 | 0 | ||
| MOTUS GI HLDGS INC | COM | 62014P108 | 510 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 20,503 | 435,300 | SH | SOLE | 435,300 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 15,000 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | |
| NEOS THERAPEUTICS INC | COM | 64052L106 | 2,341 | 482,600 | SH | SOLE | 482,600 | 0 | 0 | ||
| OBSEVA SA | COM | H5861P103 | 9,646 | 535,000 | SH | SOLE | 535,000 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 23,500 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 7,989 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 9,848 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| RADIUS HEALTH INC | COM NEW | 750469207 | 3,560 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 10,056 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 1,342 | 9,500 | SH | SOLE | 9,500 | 0 | 0 | ||
| SPECTRUM PHARMACEUTICALS INC | COM | 84763A108 | 793 | 47,200 | SH | SOLE | 47,200 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 33,917 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
| TRICIDA INC | COM | 89610F101 | 7,638 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 255 | 45,500 | SH | SOLE | 45,500 | 0 | 0 | ||
| TESARO INC | COM | 881569107 | 17,555 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| UROVANT SCIENCES LTD | SHS | G9381B108 | 3,600 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| VIEWRAY INC | COM | 92672L107 | 7,020 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 47,500 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | |
| ZAFGEN INC | COM | 98885E103 | 8,768 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| ZOGENIX INC | COM NEW | 98978L204 | 9,920 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||